Alloy Therapeutics, Inc.
Last verified 2026-05-06. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $30.0Mattributed |
|---|---|
| Latest round | Funding round, $30.0M, 2026-03-31attributed |
| Founded | 2017 |
| Headquarters | Waltham, MA |
| Industry | biotech |
| Stage | unknown |
| Website | alloytx.com |
Alloy Therapeutics offers integrated drug discovery across antibodies, bispecifics, TCR mimics, genetic medicines, and cell therapy. It serves biopharma partners outsourcing computational design plus wet-lab validation. Differentiator: AI/ML predictive design fused with hands-on experimental execution.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-03-31 | Funding round | $30.0M | undisclosed |
Detected tech stack
Cloudflare, WordPress, Typekit, Adobe Fonts, Metronet Profile Picture 2.6.3, Lucky Orange, Yoast SEO 27.4, Yoast SEO Premium 23.8, reCAPTCHA, Google Tag Manager, jQuery Migrate 3.4.1, Elementor 4.0.2
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $30.0M | attributed | sec-edgar named as publisher. No document URL on file. |
| Total raised $30.0M | attributed | sec-edgar named as publisher. No document URL on file. |
| Company existence | self-reported | alloytx.com, read 2026-05-06 |
| Description | self-reported | alloytx.com, read 2026-05-06 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $30.0M, 2026-03-31 → Funding round, $30.0M, 2026-03-31, sec-edgar, No document URL on file | Latest round | seed, $30.0M, 2026-03-31 → Funding round, $30.0M, 2026-03-31 | sec-edgar, No document URL on file |
Records begin 2026-09-24. All changes